Category: Gene Therapy
Gene Therapy market research reports by Roots Analysis
-
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation (Preclinical, Clinical and Commercial), Type of Vector (AAV Vectors, Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors and Other Vectors), Application Area (Gene Therapies, Cell Therapies and Vaccines), Therapeutic Area (Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders and Other Disorders), Type of Manufacturer (In-house and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation (Preclinical, Clinical and Commercial), Type of Vector (AAV Vectors, Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors and Other Vectors), Application Area (Gene Therapies, ... Read More
-
Single Use Bioreactors Market by Type of Bioreactor (Stirred Tank Bioreactors, Wave-Induced Bioreactors and Other Bioreactors), Scale of Operation (Preclinical / Clinical and Commercial), Type of Cell Culture (Mammalian, Insect, Microbial, Viral, Plant and Bacterial), Type of Biologics Synthesized (Vaccine, Monoclonal Antibody, Recombinant Protein, Stem Cell, Cell Therapy, and Gene Therapy), Application Area (Cancer Research, Stem Cell Research, Tissue Engineering / Regenerative Medicine, Drug Discovery / Toxicity Testing and Others), End-users (Biopharmaceutical / Pharmaceutical Industries, Academic / Research Institutes), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, Till 2035
Single Use Bioreactors Market by Type of Bioreactor (Stirred Tank Bioreactors, Wave-Induced Bioreactors and Other Bioreactors), Scale of Operation (Preclinical / Clinical and Commercial), Type of Cell Culture (Mammalian, Insect, Microbial, Viral, Plant and Bacterial), Type of Biologics Synthesized ( ... Read More
-
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunol ... Read More
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / ... Read More
-
Gene Therapy Market (6th Edition): Industry Trends and Global Forecasts, Till 2035
Gene Therapy Market (6th Edition): Industry Trends and Global Forecasts, Till 2035 The Global Gene Therapy Market is valued at USD 2.4 billion in 2024 growing at a CAGR of 19.25% during the forecast period 2024-2035. A diverse range of disorders arising from congenital abnormalities and inherited ge ... Read More
-
Cell and Gene Therapy CRO Market (4th Edition)
Cell and Gene Therapy CRO Market (4th Edition) The Cell and Gene Therapy CRO Market is valued at USD 1,653 million in 2024 growing at a CAGR of 7.1% during the forecast period 2024-2035. Cell and gene therapy candidates have shown promising outcomes in treating rare and complex diseases, including c ... Read More
-
Cell and Gene Therapy Supply Chain Software Market
Cell and Gene Therapy Supply Chain Software Market - Distribution by Process Component (Sample Collection and Processing Component, Manufacturing Component, Logistics Component, and Patient Identification and Treatment Follow-Up Component), Type of Software (EMS, LIMS, IMS, COP, QMS, LMS and PMS), M ... Read More
-
Biologics Fill / Finish Services Market (3rd Edition), 2022-2035
Biologics Fill / Finish Services Market (3rd Edition), 2022-2035 The advent of biologics marked the beginning of a new era in the pharmaceutical industry. Over time, the growing promise of biopharmaceuticals has captured the interest of various industry and academic stakeholders. Currently, more th ... Read More
-
Plant-based Biologics and Expression Systems Market, 2022-2035
Plant-based Biologics and Expression Systems Market, 2022-2035 A significant rise in the popularity of biologics has been observed over the years. The demand for such treatment modalities further witnessed a surge post the onset of the COVID-19 pandemic. At present, about 85% of the drug candidates ... Read More
-
Cell and Gene Therapy CROs Market, 3rd Edition, 2022-2035
Cell and Gene Therapy CROs Market, 3rd Edition, 2022-2035 Cell and gene therapy candidates have been demonstrated to have the potential to treat rare and complex diseases, including indications, for which no effective treatment is currently available. In this context, it is important to mention that ... Read More
-
Gene Therapy Market (5th Edition)
Gene Therapy Market (5th Edition) INTRODUCTION Over the last two decades, there have been several breakthroughs related to the development of gene therapies. In 2020, Libmeldy™, an ex vivo gene therapy received approval for the treatment of metachromatic leukodystrophy. To provide more context, the ... Read More
-
Plasmid DNA Manufacturing Market, 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates)
Plasmid DNA Manufacturing Market, 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates) PLASMID DNA MANUFACTURING MARKET OVERVIEW The global plasmid DNA manufacturing market is estimated to grow at compounded annual growth rate (CAGR) of ~15% during the forecast period of 2023-2035. The ... Read More
-
Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035
Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035 INTRODUCTION Nucleic acid-based therapies have been demonstrated to be capable of targeting genetic blueprints in order to enable treatment of a range of disease indications. Over the years, an increasing number of nucleic a ... Read More
-
Cell and Gene Therapy Bioassay Services Market, 2021-2030
Cell and Gene Therapy Bioassay Services Market, 2021-2030 INTRODUCTION Given the various advantages of cell and gene therapies and their ability to address the underlying causes of serious clinical conditions, the preference for such therapeutic modalities has increased over the years. As a result, ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Oph ... Read More
-
Liposome Development and Manufacturing Services Market, 2022-2035
Liposome Development and Manufacturing Services Market, 2022-2035 Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have concerns related to solubility and / or permeability. Therefore, players engaged in the pharmaceutical i ... Read More
-
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (5th Edition), 2022-2035
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (5th Edition), 2022-2035 With the increasing number of cell and gene therapies being developed and launched for a wide range of therapeutic areas, these modalities are on their way to become one of the highest valued markets in t ... Read More
-
Gene Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR-T Cell Therapies, Gene Therapies and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
Gene Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR-T Cell Therapies, Gene Therapies and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Pa ... Read More
-
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035 Given the potential of gene therapies in targeting the underlying cause of a disease at cellular level, the demand for such therapies has increased considerably over the past few years. Currently, ... Read More
-
Investor Series: Opportunities in the Cell and Gene Therapy Market
Investor Series: Opportunities in the Cell and Gene Therapy Market Contemporary medical science has traced thousands of clinical conditions to a genetic cause. Cancer, a life-threatening disease, also has genetic origins, and is considered among the leading causes of death across the globe. In fact, ... Read More
-
Gene Therapies & Associated Vectors: Intellectual Property Landscape
Gene Therapies & Associated Vectors: Intellectual Property Landscape Although speculations related to using tailored DNA / RNA sequences to cure genetic disorders were made as early as the 1960s, the first reported use of a gene therapy was in 1990, to treat adenosine deaminase (ADA) deficiency rela ... Read More
Research Assistance
